Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
30.2 USD | 0.00% | +6.26% | +175.95% |
02:21pm | Leerink Partners Starts Q32 Bio With Outperform Rating | MT |
09/05 | Q32 Bio Inc. Provides Corporate Update | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+175.95% | 360M | |
+8.97% | 115B | |
+12.51% | 107B | |
-12.85% | 22.31B | |
-3.61% | 21.6B | |
-5.65% | 18.23B | |
-38.57% | 17.62B | |
+7.26% | 14.26B | |
+35.23% | 12.37B | |
-25.59% | 8.28B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Oppenheimer Downgrades Homology Medicines to Perform From Outperform, Removes $22 Price Target